These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3694130)

  • 1. Radioimmunoassay of 11 beta-hydroxyandrostenedione in laboratory diagnostics of selected endocrine disorders.
    Putz Z; Hampl R; Velemínský J; Kreze A; Sulcová J; Stárka L
    J Clin Chem Clin Biochem; 1987 Oct; 25(10):723-7. PubMed ID: 3694130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous radioimmunoassay of androstenedione, dehydroepiandrosterone and 11-beta-hydroxyandrostenedione in plasma.
    Fiet J; Gourmel B; Villette JM; Brerault JL; Julien R; Cathelineau G; Dreux C
    Horm Res; 1980; 13(3):133-49. PubMed ID: 6259044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ratio of androstenedione:11 beta-hydroxyandrostenedione is an important marker of adrenal androgen excess in women.
    Carmina E; Stanczyk FZ; Chang L; Miles RA; Lobo RA
    Fertil Steril; 1992 Jul; 58(1):148-52. PubMed ID: 1623996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective radioimmunoassay of androstenedione in plasma and saliva.
    Putz Z; Hampl R; Vanŭga A; Veleminský J; Stárka L
    J Clin Chem Clin Biochem; 1982 Oct; 20(10):761-4. PubMed ID: 7142915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is 11 beta-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate?
    Stanczyk FZ; Chang L; Carmina E; Putz Z; Lobo RA
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 1):1837-42. PubMed ID: 1836306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma 19-hydroxyandrostenedione levels in Cushing's disease: stimulation with ACTH and inhibition with metyrapone.
    Mune T; Morita H; Yasuda K; Murayama M; Yamakita N; Miura K
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):265-72. PubMed ID: 8384536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The measurement of 4-androstene-3, 11, 17-trione (11-oxo-androstenedione) by radioimmunoassay in human plasma.
    Schlaghecke R; Kley HK; Krüskemper HL
    Steroids; 1984 Jul; 44(1):23-33. PubMed ID: 6100340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II induces the release of 19-hydroxyandrostenedione in man.
    Sekihara H; Torii R; Osawa Y; Takaku F
    J Clin Endocrinol Metab; 1985 Aug; 61(2):291-6. PubMed ID: 2989318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adrenocorticotropin on adrenal and plasma 11 beta-hydroxyandrostenedione in the guinea pig and determination of its relative androgen potency.
    Bélanger B; Fiet J; Bélanger A
    Steroids; 1993 Jan; 58(1):29-34. PubMed ID: 8381568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to 4-hydroxyandrostenedione--a new anti-breast cancer agent suitable for use in a radioimmunoassay.
    Khubieh J; Aherne GW; Chakraborty J
    Cancer Chemother Pharmacol; 1987; 19(2):175-6. PubMed ID: 3568276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a sensitive and specific new plasma 4-androstene-3,17- dione time-resolved fluoroimmunoassay (TR-FIA).
    Fiet J; Giton F; Boudi A; Boudou P; Soliman H; Villette JM; Galons H
    Steroids; 2001 Aug; 66(8):609-14. PubMed ID: 11430993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The measurement of androst-4-en-17 beta-ol-3,11-dione (11-oxotestosterone) by radioimmunoassay in human plasma.
    Kley HK; Schlaghecke R; Krüskemper HL
    J Clin Chem Clin Biochem; 1984 Jul; 22(7):461-6. PubMed ID: 6090577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved radioimmunoassay for 4-androstene-3,17-dione.
    Parker LN; Grover PK; Odell WD
    Steroids; 1977 Jun; 29(6):715-24. PubMed ID: 910247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of androstenedione levels by an in-house radioimmunoassay.
    Lo MS; Ng ML; Wu LL; Khalid BA
    Malays J Pathol; 1996 Jun; 18(1):53-8. PubMed ID: 10879225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma estradiol concentrations and effect of HCG on plasma estradiol and testosterone in normal subjects and patients with endocrine disorders.
    Ishimaru T
    Endocrinol Jpn; 1975 Aug; 22(4):287-96. PubMed ID: 1201738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma 11beta-hydroxy-4-androstene-3,17-dione: comparison of a time-resolved fluoroimmunoassay using a biotinylated tracer with a radioimmunoassay using a tritiated tracer.
    Ibrahim F; Giton F; Boudou P; Villette JM; Julien R; Galons H; Fiet J
    J Steroid Biochem Mol Biol; 2003 Apr; 84(5):563-8. PubMed ID: 12767281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Exaggerated adrenarche' in children presenting with premature adrenarche.
    Likitmaskul S; Cowell CT; Donaghue K; Kreutzmann DJ; Howard NJ; Blades B; Silink M
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):265-72. PubMed ID: 7758231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma 19-hydroxyandrostenedione is elevated in patients with high renin essential hypertension.
    Sekihara H; Yonemitsu K; Yazaki Y
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):557-60. PubMed ID: 8252745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 11 beta-hydroxyandrostenedione as an indicator of the source of excess androgen production in women with polycystic ovaries.
    Polson DW; Reed MJ; Franks S; Scanlon MJ; James VH
    J Clin Endocrinol Metab; 1988 May; 66(5):946-50. PubMed ID: 3129451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma 16 beta-hydroxydehydroepiandrosterone in normal and pathological conditions in man.
    Sekihara H; Sennett JA; Liddle GW; McKenna TJ; Yarbro LR
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1078-84. PubMed ID: 186475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.